Hisamitsu Pharmaceutical

(OTC) HTSUF

Current Price$28.59

Market Cap$2.04B

Since IPO (2005)+9%

5 Year-48%

1 Year+7%

1 Month+0%

Hisamitsu Pharmaceutical Financials at a Glance

Market Cap

$2.04B

Revenue (TTM)

$163.09B

Net Income (TTM)

$19.17B

EPS (TTM)

$1.78

P/E Ratio

16.32

Dividend

$0.31

Beta (Volatility)

-0.02 (Low)

Dividend

$0.31

Beta (Volatility)

-0.02 (Low)

Price

$28.59

Volume

Open

$28.59

Price

$28.59

Volume

Open

$28.59

Previous Close

$28.59

Daily Range

$28.59 - $28.59

52-Week Range

$28.59 - $32.19

Dividend

$0.31

Beta (Volatility)

-0.02 (Low)

Price

$28.59

Volume

Open

$28.59

Previous Close

$28.59

Daily Range

$28.59 - $28.59

52-Week Range

$28.59 - $32.19

HTSUF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Hisamitsu Pharmaceutical

Industry

Pharmaceuticals

Sector

Health Care

Employees

2,799

CEO

Hirotaka Nakatomi

Website

www.hisamitsu.co.jp

Headquarters

Tosu, 841-0017, JP

HTSUF Financials

Key Financial Metrics (TTM)

Gross Margin

59%

Operating Margin

11%

Net Income Margin

12%

Return on Equity

Return on Capital

Return on Assets

Earnings Yield

6.13%

Dividend Yield

1.06%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.04B

Shares Outstanding

70.40M

Volume

Avg. Volume

14.794

Financials (TTM)

Gross Profit

$96.40B

Operating Income

$17.97B

EBITDA

$25.04B

Operating Cash Flow

$17.53B

Capital Expenditure

$8.02B

Free Cash Flow

$9.51B

Cash & ST Invst.

$118.98B

Total Debt

$2.38B

Hisamitsu Pharmaceutical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2026YOY CHG

Revenue

$48.65B

+8.7%

Gross Profit

$26.96B

+8.7%

Gross Margin

55.42%

N/A

Market Cap

$2.04B

N/A

Market Cap/Employee

$740.00K

N/A

Employees

2,759

N/A

Net Income

$7.29B

-10.0%

EBITDA

$7.14B

-1.6%

Quarterly Fundamentals

Name

Q4 2026YOY CHG

Net Cash

$116.60B

-6.9%

Accounts Receivable

$56.48B

+20.5%

Inventory

$25.99B

+16.1%

Long Term Debt

$1.13B

-52.7%

Short Term Debt

$1.25B

-14.9%

Return on Assets

5.22%

N/A

Return on Invested Capital

5.66%

N/A

Free Cash Flow

$0.00

N/A

Operating Cash Flow

$0.00

N/A

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CURLFCuraleaf Holdings, Inc.

CURLFCuraleaf Holdings, Inc.$3.39-3.69%

CASBFCanSino Biologics Inc.

CASBFCanSino Biologics Inc.$3.86+0.00%

BRCTFBioArctic AB (publ)

BRCTFBioArctic AB (publ)$33.02+0.00%

LBTSFAlmirall, S.A.

LBTSFAlmirall, S.A.$15.35-0.78%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$99.62+0.05%

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

TSLATesla

TSLATesla$390.82+0.02%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

Questions About HTSUF

What is the current price of Hisamitsu Pharmaceutical?

Hisamitsu Pharmaceutical is trading at $28.59 per share.

What is the 52-week range for Hisamitsu Pharmaceutical?

Over the past 52 weeks, Hisamitsu Pharmaceutical has traded between $28.59 and $32.19.

How much debt does Hisamitsu Pharmaceutical have?

As of the most recent reporting period, Hisamitsu Pharmaceutical reported total debt of $15.21M.

How much cash does Hisamitsu Pharmaceutical have on hand?

Hisamitsu Pharmaceutical reported $697.26M in cash and cash equivalents in its most recent financial results.

What is Hisamitsu Pharmaceutical’s dividend yield?

Hisamitsu Pharmaceutical currently has a dividend yield of 1.06%.

Hisamitsu Pharmaceutical

Hisamitsu Pharmaceutical Financials at a Glance

HTSUF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Hisamitsu Pharmaceutical

HTSUF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Hisamitsu Pharmaceutical Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About HTSUF

What is the current price of Hisamitsu Pharmaceutical?

What is the 52-week range for Hisamitsu Pharmaceutical?

How much debt does Hisamitsu Pharmaceutical have?

How much cash does Hisamitsu Pharmaceutical have on hand?

What is Hisamitsu Pharmaceutical’s dividend yield?

Premium Investing Services